Literature DB >> 3035204

Meso-2,3-dimercaptosuccinic acid in the diagnosis and treatment of lead poisoning.

Y Bentur, J G Brook, R Behar, U Taitelman.   

Abstract

Lead poisoning remains one of the hazards of industrialized civilization. CaNa2 EDTA and dimercaprol, the usual therapeutic measures, have many side effects and can be given by parenteral route alone. The authors present a case of chronic lead poisoning caused by ingestion of contaminated flour ground in a primitive flour mill. The diagnosis was confirmed by the CaNa2 EDTA provocative test. Dimercaptosuccinic acid (DMSA) was given orally as a further provocation and resulted in an 11-fold increase in urinary lead excretion. A 5-day course of treatment with DMSA was instituted, during which symptoms abated, urinary lead excretion increased and the blood lead level decreased. No side effects were noticed. There has been no relapse over several months of follow-up. The authors conclude that the oral use of DMSA is effective, safe and convenient both as a provocative test in establishing the diagnosis of lead poisoning and as a therapeutic tool.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035204     DOI: 10.3109/15563658708992612

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  5 in total

1.  Lead encephalopathy from an imported Toby mug.

Authors:  M A Zuckerman; D Savory; G Rayman
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

2.  Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites.

Authors:  B K Lee; B S Schwartz; W Stewart; K D Ahn
Journal:  Occup Environ Med       Date:  1995-01       Impact factor: 4.402

3.  An oral treatment for lead toxicity.

Authors:  P S Thomas; C Ashton
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

Review 4.  The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning.

Authors:  D E Glotzer
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

5.  Reductions in blood lead overestimate reductions in brain lead following repeated succimer regimens in a rodent model of childhood lead exposure.

Authors:  Diane E Stangle; Myla S Strawderman; Donald Smith; Mareike Kuypers; Barbara J Strupp
Journal:  Environ Health Perspect       Date:  2004-03       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.